Literature DB >> 8020643

Platelet factor 4, beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients.

M Bayraktar1, S Dündar, S Kirazli, F Teletar.   

Abstract

The proteins beta-thromboglobulin, platelet factor 4 and thrombospondin are stored in platelet alpha-granules and released from the platelet by the release reaction. The assays of these proteins were studied in patients with type I diabetes mellitus (n = 30) and a healthy control group (n = 15). Platelet factor 4 and beta-thromboglobulin levels were not significantly different in both groups but thrombospondin concentrations in diabetic patients were significantly higher than those of the control group (136.6 +/- 14.2 ng/ml vs 91.2 +/- 14.3 ng/ml, P < 0.05). When the diabetic patients were divided into those with or without complications, the diabetic patients with complications (n = 11) had significantly elevated plasma thrombospondin concentrations compared with the control group (150.4 +/- 23.7 ng/ml vs 91.2 +/- 14.3 ng/ml, P < 0.05), while thrombospondin concentrations in the control group were not statistically different from the diabetic patients without complications. Plasma beta-thromboglobulin and platelet factor 4 levels were not significantly different between the diabetic and the control group. It is suggested that thrombospondin may be a convenient marker of in vivo platelet release reaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020643     DOI: 10.1177/030006059402200204

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  12 in total

1.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.

Authors:  Michael J Kraakman; Man Ks Lee; Annas Al-Sharea; Dragana Dragoljevic; Tessa J Barrett; Emilie Montenont; Debapriya Basu; Sarah Heywood; Helene L Kammoun; Michelle Flynn; Alexandra Whillas; Nordin Mj Hanssen; Mark A Febbraio; Erik Westein; Edward A Fisher; Jaye Chin-Dusting; Mark E Cooper; Jeffrey S Berger; Ira J Goldberg; Prabhakara R Nagareddy; Andrew J Murphy
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

3.  Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.

Authors:  Eileen M Bauer; Yan Qin; Thomas W Miller; Russell W Bandle; Gabor Csanyi; Patrick J Pagano; Philip M Bauer; Jurgen Schnermann; David D Roberts; Jeff S Isenberg
Journal:  Cardiovasc Res       Date:  2010-07-07       Impact factor: 10.787

4.  A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose.

Authors:  Priya Raman; Christy Harry; Malory Weber; Irene Krukovets; Olga I Stenina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-09       Impact factor: 8.311

5.  Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.

Authors:  Rituparna Ganguly; Amy M Wen; Ashley B Myer; Tori Czech; Soumyadip Sahu; Nicole F Steinmetz; Priya Raman
Journal:  Nanoscale       Date:  2016-03-28       Impact factor: 7.790

Review 6.  Thrombospondin-1 in maladaptive aging responses: a concept whose time has come.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

7.  Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance.

Authors:  Vijayalakshmi Varma; Aiwei Yao-Borengasser; Angela M Bodles; Neda Rasouli; Bounleut Phanavanh; Greg T Nolen; Emily M Kern; Radhakrishnan Nagarajan; Horace J Spencer; Mi-Jeong Lee; Susan K Fried; Robert E McGehee; Charlotte A Peterson; Philip A Kern
Journal:  Diabetes       Date:  2007-12-05       Impact factor: 9.461

8.  TGF-β and Diabetic Nephropathy: Lessons Learned Over the Past 20 Years.

Authors:  Leslie S Gewin
Journal:  Am J Med Sci       Date:  2019-11-29       Impact factor: 3.462

9.  Thrombospondin-1/CD36 pathway contributes to bone marrow-derived angiogenic cell dysfunction in type 1 diabetes via Sonic hedgehog pathway suppression.

Authors:  Jie-Mei Wang; Jeffery S Isenberg; Timothy R Billiar; Alex F Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-22       Impact factor: 4.310

10.  Feeding sugar to tumors: with a supplement of miR?

Authors:  Olivier P Blanc-Brude; Alain Tedgui
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.